- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05255068
OPTIMAL in NH Residents With Dementia
Optimizing Mealtime Care (OPTIMAL): Development and Pilot Testing of a Person-Centered Mealtime Care Intervention for Nursing Home Residents With Alzheimer's Disease and Related Dementias (ADRD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study developed and refined OPTIMAL, and evaluated its feasibility, fidelity, and usefulness. We used mixed methods (i.e., focus groups, a pilot single-group repeated measures) to refine and test OPTIMAL. We collected repeated measures at 3 time points: baseline (T1), immediately post intervention (6 weeks post baseline, T2), and 6-week post intervention (12 weeks post baseline, T3). At each time point, we assessed quality of staff engagement and resident outcomes including eating performance and BMI through collection and coding of videotaped observations of dyadic mealtime interaction (videos; Aim 2&3) over 6 meals in 2 consecutive days (2 breakfasts, 2 lunches, 2 dinners) for each staff-resident dyad. We used Cue Utilization and Engagement in Dementia (CUED) mealtime video coding scheme, an innovative, feasible, and reliable tool that our team has developed and validated, and assessed resident mealtime challenging behaviors including resistive behaviors and functional impairments and intake success rate using videos collected in this study.11, 25
The specific aims are:
- Develop, evaluate, and refine OPTIMAL intervention protocol and training materials. We will integrate evidence from literature and our prior work to develop the intervention protocol and training materials, addressing resident mealtime difficulties, targeted PCMC strategies, and establishment of individualized PCMC plans. We will conduct separate focus group interviews of staff and family participants on the acceptability and appropriateness of the intervention protocol and training materials before pilot testing. Data obtained will be used to refine the intervention protocol and training materials before pilot testing.
- Determine feasibility, fidelity, and usefulness of OPTIMAL. Feasibility on participant identification, recruitment, consent, and retention will be evaluated descriptively. Fidelity will be assessed on a) delivery of treatment (staff attendance to training sessions), b) receipt of treatment (staff knowledge and self-efficacy pre- & post-training), and c) enactment of treatment skills (staff PCMC&TCMC behaviors, quality of staff engagement). We will conduct focus group interviews of staff to assess the usefulness of OPTIMAL after T3.
- Describe resident outcomes (Exploratory). We will measure and describe resident mealtime difficulties, eating performance, intake success rate, body weight, and body mass index using descriptive statistics over time for two treatment groups. Data obtained will inform estimates of effect sizes for a future larger-scale trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Marshalltown, Iowa, United States, 50158
- Iowa Vateran's Home
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
The investigators will recruit direct care staff, families of residents, and residents with dementia from NH sites following the exclusion and inclusion criteria after attrition rates are considered.
Inclusion Criteria:
Residents
- ≥ 55 years
- Diagnosed as having ADRD based on medical records
- Identified by NH staff as requiring mealtime assistance
- Having a legally authorized representative (LAR) providing informed written consent
Staffs
- ≥18 years
- English speaking
- A permanent facility employee
- Provide direct mealtime care for a resident participant at least twice a week over the previous month
Families
- ≥18 years
- English speaking
- A family member of the resident who is living at the NH study site at the time of the study
- Having experience of delivering mealtime care to their resident family members
Exclusion Criteria:
Residents
- Have a documented diagnosis of Parkinson's disease, traumatic brain injury, or swallowing disorder,
- Do not eat orally (e.g., parenteral/IV feedings, feeding tubes)
- Unable to hear or see staff even with glasses and/or hearing aids (e.g., uncorrected visual or hearing impairment)
- Stay in the NH study site for less than 12 weeks at the time of recruitment/consent/assent (e.g., terminally ill receiving hospice services, and/or receiving post-hospital skilled rehabilitation) that may not allow enough time for obtaining consent/assent, and scheduling days for video recording sessions across three-time points (baseline, and 6- and 12- weeks post-baseline)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Staff
Start participants who enrolled in the study, received the OPTIMAL intervention, and were observed during data collection.
|
A person-centered mealtime care intervention
|
|
Experimental: Resident
Resident participants who were cared in the study site, and received care from the staff participants before and after the OPTIMAL intervention was delivered to staff.
|
A person-centered mealtime care intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Staff Participants Who Viewed the Intervention as Appropriate and Acceptable for Mealtime Care Practice
Time Frame: After recruitment of staff participants and before T1 (baseline)
|
All staff participants were interviewed on whether the intervention protocol and training materials were acceptable and appropriate for nursing home mealtime care practice before pilot testing.
|
After recruitment of staff participants and before T1 (baseline)
|
|
Number of Staff and Resident Participants Recruited and Retained for the Study
Time Frame: From recruitment/consent throughout the study completion, up to 12-weeks post baseline
|
The number of staff and resident participants that were recruited at baseline and retained over the study period were collected to indicate the feasibility of the study on participant recruitment, consent and retention.
|
From recruitment/consent throughout the study completion, up to 12-weeks post baseline
|
|
The Number of Staff Participants Who Attended All Training Sessions
Time Frame: During each OPTIMAL training session (within 2 weeks post baseline)
|
A checklist was used to track the number of staff participants who attended all the group and/or individual training sessions that were provided in the study.
|
During each OPTIMAL training session (within 2 weeks post baseline)
|
|
Staff Person-centered Care Knowledge and Self-efficacy
Time Frame: Right before and after OPTIMAL training session (within 2 weeks post baseline)
|
Training receipt, indicated by a total score of ≥ 75% on the staff PCMC-related knowledge & self-efficacy test post-training with or without booster sessions.
The total score of the scale ranges from 0 - 20, and higher scores are better.
we recorded the number of staff who reached this cutoff score post training.
|
Right before and after OPTIMAL training session (within 2 weeks post baseline)
|
|
Number of Staff Participants Who Viewed the Intervention Was Useful
Time Frame: After T3 data collection time point (12-weeks post baseline)
|
All staff participants were interviewed on whether the intervention was useful post testing.
The number of staff participants who viewed the intervention was useful was collected.
|
After T3 data collection time point (12-weeks post baseline)
|
|
The Number of Mealtime Difficulty Behaviors Observed in Residents
Time Frame: T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Videos will be coded using the Cue Utilization and Engagement in Dementia (CUED) mealtime video coding scheme that have codes for resident mealtime difficulties including 1) resistive behaviors and 2) functional impairments.
we recorded the number of behaviors representing mealtime difficulties presented by residents, the higher the number, the worse the outcome.
|
T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
|
Resident Level of Eating Performance
Time Frame: T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Level of Eating Independence Scale, a 9-item scale assessing the ability of independence with eating and drinking activities during cycles of verbal prompts, will be used to measure.
Each item is scored from 1 (total dependence) to 4 (total independence), with total score ranging from 9 to 36 (higher score = more independence).
|
T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
|
Resident Intake Success Rate
Time Frame: T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Videos will be coded using CUED to track whether the resident or staff initiates/completes each intake attempt and whether there is a subsequent intake after each attempt.
Resident intake success rate will be calculated by dividing the number of intake attempts initiated/completed by the resident with subsequent intake by the total number of intake attempts coded during one meal.
the percent can range from 0 - 100%, the higher the number, the more independent the resident.
|
T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Staff Engagement
Time Frame: T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Quality of staff engagement will be assessed by Mealtime Engagement Scale developed by the PI with evidence of reliability and validity (each item is scored on 0-3, total score range: 0-57, higher score = higher quality of engagement).
|
T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
|
Resident Body Mass Index (BMI).
Time Frame: T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Resident Body Mass Index (BMI, unit is kg/m2).
We will assess body weight in the early morning before breakfast with each individual resident dressing casual indoor clothes without shoes using the same digital body scale throughout the study.
We will assess body weight twice in one early morning of each time point and calculate the average of the two assessments for BMI.
|
T1 (baseline), T2 (6-weeks post baseline), T3 (12-weeks post baseline)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Liu Wen, PhD, The University Of Iowa College Of Nursing
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K23AG066856 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease and Related Dementias
-
Penn State UniversityCompletedAlzheimer's Disease and Related DementiasUnited States
-
Northwell HealthNational Institute of Nursing Research (NINR); Penn State UniversityCompletedAlzheimer's Disease and Related DementiasUnited States
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)Completed
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Completed
-
Northwell HealthNational Institute of Nursing Research (NINR); Penn State UniversityCompletedAlzheimer's Disease and Related DementiasUnited States
-
Harvard Pilgrim Health CareNational Institute on Aging (NIA); Tufts Health PlanCompletedAlzheimer's Disease and Related Dementias (ADRD)United States
-
Arizona State UniversityRecruitingAlzheimer's Disease and Related Dementias Family CaregiversUnited States
-
Florida State UniversityNational Institute of Nursing Research (NINR)CompletedAlzheimer's Disease and Related DementiasUnited States
-
University of South FloridaNational Institute on Aging (NIA)RecruitingAge-related Cognitive Decline | Alzheimer's Disease and Related DementiasUnited States
-
University of Colorado, DenverRecruitingHospice | Alzheimer's Disease and Related Dementias | Sexual and Gender MinoritiesUnited States
Clinical Trials on OPTIMAL
-
Karolinska InstitutetSt. Claraspital AGWithdrawnDiabetic Kidney DiseaseSweden, Switzerland
-
Loewenstein HospitalAriel UniversityUnknownChronic Pain | Traumatic Brain Damage
-
Penn State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedDown Syndrome | Augmentative and Alternative CommunicationUnited States
-
Uptake Medical Technology, Inc.MedPass InternationalTerminated
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaUnited States, Spain, France, Israel, Netherlands, Greece, Italy
-
NTK Enterprises, Inc.Terminated
-
Toad Medical CorporationUniversity Hospitals Cleveland Medical CenterUnknownDiabetic Foot | Pedal UlcersUnited States
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR); MedtronicCompletedHeart Failure, CongestiveCanada, Netherlands, Australia, Turkey, Denmark, Germany, Belgium
-
Mei-Yun ChangCompletedAcute Respiratory Distress SyndromeTaiwan